Wellington Management Group’s BridgeBio Oncology BBOT Stock Holding History

Wellington Management Group’s Portfolio BBOT Stock Details BBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.3M	Sell	2,789,302 -29,046	-1%	-$242K	﹤0.01%	1049
2026 Q1	$25.2M	Sell	2,818,348 -88,655	-3%	-$952K	﹤0.01%	924
2025 Q4	$36.4M	Sell	2,907,003 -54,260	-2%	-$657K	0.01%	827
2025 Q3	$34.3M	Buy	2,961,263 +2,776,673	+1,504%	+$28.9M	0.01%	838
2025 Q2	$1.97M	Hold	184,590	–	–	﹤0.01%	1585
2025 Q1	$2.09M	Hold	184,590	–	–	﹤0.01%	1550
2024 Q4	$1.94M	Sell	184,590 -80	-0%	-$842	﹤0.01%	1571
2024 Q3	$1.93M	Hold	184,670	–	–	﹤0.01%	1548
2024 Q2	$1.89M	Sell	184,670 -17,490	-9%	-$180K	﹤0.01%	1531
2024 Q1	$2.09M	Buy	+202,160	New	+$2.09M	﹤0.01%	1512

Other funds holding BBOT

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group's BBOT Position: Q2 2026 in Review

Wellington Management Group reduced its BridgeBio Oncology (BBOT) stake by 1% in Q2 2026, selling an estimated $242K and leaving 2,789,302 shares worth $21.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1049.

Wellington Management Group first reported a position in BBOT in Q1 2024 and has held it in 10 quarters since. The position peaked at $36.4M in Q4 2025. 65 funds tracked by Wall St. Rank hold BBOT as of Q2 2026.

Wellington Management Group held 2,789,302 shares of BridgeBio Oncology worth $21.3M as of Q2 2026.
Wellington Management Group sold 29,046 BridgeBio Oncology shares in Q2 2026, an estimated $242K.
BridgeBio Oncology made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1049 holding.
Wellington Management Group first reported a position in BridgeBio Oncology in Q1 2024 and has held it in 10 quarters since.
Wellington Management Group's BridgeBio Oncology position peaked at $36.4M in Q4 2025.
65 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.